Form 4: Teladoc Health Executive Adam Vandervoort Reports Stock Transactions

Adam Vandervoort, Chief Legal Officer and Secretary of Teladoc Health, reports the acquisition and disposal of common stock and derivative securities, including performance stock units and restricted stock units, between March 1 and March 4, 2024.

Summary

• Adam Vandervoort, Chief Legal Officer and Secretary of Teladoc Health, filed a Form 4 detailing changes in beneficial ownership.
• On March 1, 2024, Vandervoort acquired shares through the conversion of performance stock units and restricted stock units.
• These conversions resulted in the acquisition of 6,022, 730, 1,446, 1,881, 17,671, and 1,912 shares of common stock.
• On March 4, 2024, Vandervoort disposed of 15,653 shares of common stock at a price of $14.516 per share.
• Following these transactions, Vandervoort directly owns 37,476 shares of Teladoc Health common stock.
• Vandervoort also holds 18,067 Performance Stock Units.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment about the company's prospects.

Future Outlook

The performance stock units vest over time, with some vesting immediately and the remainder vesting in quarterly installments.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are often scrutinized by investors for insights into management's perspective on the company's performance and future prospects. This filing is a routine disclosure required by the SEC.

Comparison to Industry Standards

• Executive compensation packages often include stock options, restricted stock units, and performance-based awards to align management's interests with those of shareholders.
• The vesting schedules and performance metrics associated with these awards are typically benchmarked against industry peers to ensure competitiveness and effectiveness.
• Companies like Amwell and Accolade, which operate in similar telehealth markets, also utilize equity-based compensation to incentivize their executives.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, although it is a relatively small transaction.
• The vesting of performance stock units and restricted stock units aligns the executive's interests with the company's performance, which is generally viewed positively.

Key Dates